www.escardio.org
Published today - Advanced Access
European Heart Journalhttp://eurheartj.oxfordjournals.org/
www.escardio.org
Classification of Atrial Fibrillation
Paroxysmal(usually <48 h)
www.escardio.org
Time Course and Management of AF
www.escardio.org
Important Elements of the History
www.escardio.org
Symptom Scores
www.escardio.org
Diagnosis / Follow-up Class I Recommendations
www.escardio.org
Principles of Management
www.escardio.org
CHA2DS2-VASc
www.escardio.org
CHA2DS2-VASc Thromboembolic Risk Score
www.escardio.org
Selected OAC Recommendations
www.escardio.org
Bleeding Risk – HAS-BLED Score
www.escardio.org
Rate and Rhythm Control
www.escardio.org
Optimal Rate Control
www.escardio.org
Optimal Rate Control
www.escardio.org
Choice of Rate Control Medication
www.escardio.org
Antiarrhythmic Medication for Rhythm Control
www.escardio.org
Antiarrhythmic Medication for Rhythm Control
www.escardio.org
Antiarrhythmic Medication for Rhythm Control
www.escardio.org
Choice of AAD - Underlying Pathology
www.escardio.org
Catheter Ablation for Atrial Fibrillation
www.escardio.org
Indication for LA Catheter Ablation
www.escardio.org
Ablation whenSHD is Present
www.escardio.org
“Upstream” Therapy Primary PreventionACE inhibitors, Angiotensin receptor blockers, Aldosterone antagonists
Statins, PUFAs
Agents Considered:
www.escardio.org
“Upstream” Therapy – Secondary Prevention
www.escardio.org
Atrial Fibrillation in Athletes
www.escardio.orgEuropean Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)